Tecnimede Group


Tecnimede Group is a Portuguese pharmaceutical company dedicated to research, development, production, and distribution of medicines. Founded in 1980, it focuses on addressing unfulfilled medical needs and improving human life through a comprehensive medication life cycle. The group has production centers in Portugal and Morocco, with a combined capacity of over 34 million units, and exports to more than 100 countries. Tecnimede is involved in various therapeutic areas including cardiology, oncology, and central nervous system, and has a portfolio of over 130 products. The company also engages in in-licensing, out-licensing, and release of products for the European area, with certified laboratories and extensive experience in batch release. It has a strong focus on innovation, with over 440 patents, and a broad portfolio including highly active products, vitamins, minerals, and various therapeutic classes. Tecnimede supports patient organizations and maintains active participation in industry associations. The company has received recognition as the Best and Largest Company in the healthcare sector in Portugal in 2023.

Industries

Pharmaceutical
Pharmaceutical Manufacturing

Nr. of Employees

large (251-1000)

Tecnimede Group


Products

Portfolio of generics and OTC medicines

A broad portfolio of generic and over-the-counter medicines across multiple therapeutic areas (cardiometabolic, anti-infectives, nervous system, respiratory, vitamins/minerals, corticosteroids, antineoplastics, etc.).

Valsartan TecniGen 80 mg

Compresse rivestite con film contenenti 80 mg di valsartan, indicate per il trattamento dell'ipertensione arteriosa, dell'infarto miocardico recente e dell'insufficienza cardiaca.

Acetylsalicylic Acid (TENDER & HOSPITAL BUSINESS)

Cardiometabolic pharmaceutical product for tender and hospital business.

Levetiracetam TecniGen 1000 mg comprimidos recubiertos con película EFG

Levetiracetam TecniGen 1000 mg film-coated tablets indicated as monotherapy or adjunctive therapy for the treatment of epileptic seizures.

Levetiracetam TecniGen 500 mg compresse rivestite con film

Levetiracetam TecniGen is an antiepileptic medicine indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in adults and adolescents from 16 years of age with newly diagnosed epilepsy, as well as adjunctive therapy for various types of seizures in broader patient populations.

LOSARTAN E IDROCLOROTIAZIDE TECNIGEN

Compresse rivestite con film contenenti 100 mg di losartan potassico e 12,5 mg di idroclorotiazide, indicate per il trattamento dell'ipertensione essenziale.

View All Products

Services

End-to-end manufacturing services for solid oral products including granulation, blending, compression, coating and capsule filling, with containment options for high-potency products.

Physico-chemical and microbiological testing for raw materials, packaging and finished products, plus stability testing and batch release support.

Validation of manufacturing and packaging processes, analytical methods, facility cleanliness and computerized systems supporting compliance activities.

Research and development across the full product lifecycle supporting new molecule development, formulation optimization and portfolio expansion.

Support for regulatory submissions, registration maintenance and marketing authorization management across international markets.

Services to support market entry, distribution and export, including direct presence in multiple countries and international partner networks.

View All Services

Expertise Areas

  • Pharmaceutical manufacturing (solid, semi-solid, liquids and suspensions)
  • High-potency/contained manufacturing for oncology products
  • Quality control and analytical testing (release and stability)
  • Quality assurance and method/computerized system validation
  • Show More (9)

Key Technologies

  • Wet/dry granulation and drying
  • Powder blending
  • Tableting / compression
  • Film and functional coating for solid dosage forms
  • Show More (12)

News & Updates

Tecnimede Group shared its experience in international markets, discussing strategies for internationalization and domestic profit generation.

Evaluation of Atlas Pharm, Tecnimede's production unit in Morocco dedicated to oncological treatments.

Showcasing its portfolio at the largest pharmaceutical event, reinforcing partnerships and exploring international opportunities.

Official launch event for the Tecnigen brand, discussing market trends and challenges for generics in Portugal and Europe.

Tecnimede was considered the top company in the healthcare sector according to Exame Portugal magazine.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.